<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>conjugated linoleic acid &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/conjugated-linoleic-acid/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Thu, 08 Oct 2026 20:30:28 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>conjugated linoleic acid &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Ruthenium-Nickel Duo on Mesoporous Silica Turns Linoleic Acid into Health-Boosting Conjugated Fatty Acids</title>
		<link>https://scienmag.com/ruthenium-nickel-duo-on-mesoporous-silica-turns-linoleic-acid-into-health-boosting-conjugated-fatty-acids/</link>
		
		<dc:creator><![CDATA[Bethany Barker]]></dc:creator>
		<pubDate>Thu, 08 Oct 2026 20:30:28 +0000</pubDate>
				<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[advanced catalyst design for]]></category>
		<category><![CDATA[bimetallic catalyst]]></category>
		<category><![CDATA[bimetallic synergy in catalysis]]></category>
		<category><![CDATA[catalyst recyclability]]></category>
		<category><![CDATA[catalyst reusability in fatty acid transformation]]></category>
		<category><![CDATA[catalytic conversion of linoleic acid]]></category>
		<category><![CDATA[chemical engineering for health supplements]]></category>
		<category><![CDATA[conjugated linoleic acid]]></category>
		<category><![CDATA[fatty acid chemistry]]></category>
		<category><![CDATA[green catalysis]]></category>
		<category><![CDATA[heterogeneous catalysis]]></category>
		<category><![CDATA[linoleic acid isomerization]]></category>
		<category><![CDATA[mesoporous silica]]></category>
		<category><![CDATA[mesoporous silica supports in catalysis]]></category>
		<category><![CDATA[nickel]]></category>
		<category><![CDATA[ruthenium]]></category>
		<category><![CDATA[Ruthenium-nickel bimetallic catalyst for fatty acid conversion]]></category>
		<category><![CDATA[SBA-15]]></category>
		<category><![CDATA[SBA-15 mesoporous silica applications]]></category>
		<category><![CDATA[scalable chemical processes for health-promoting fatty acids]]></category>
		<category><![CDATA[sustainable production of bioactive fatty acids]]></category>
		<category><![CDATA[synergistic effect]]></category>
		<category><![CDATA[synthesis of conjugated linoleic acid (CLA)]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=249145</guid>

					<description><![CDATA[Chinese researchers have developed a recyclable ruthenium-nickel bimetallic catalyst on ordered mesoporous silica that converts linoleic acid into conjugated linoleic acid with a 65 percent yield while suppressing unwanted hydrogenation.]]></description>
										<content:encoded><![CDATA[<p>Conjugated linoleic acid, or CLA, has spent decades in the scientific spotlight as a fatty acid with an intriguing portfolio of reported biological effects, from influences on body composition and inflammation to immunomodulatory properties noted in the nutrition literature. Yet producing this compound cleanly and at scale has remained a stubborn chemical challenge. A team of researchers at Jiangnan University in Wuxi, China, now reports a catalyst design that could change that calculus. Writing in Catalysis Letters, Yigao Li, Shouteng Zheng, and colleagues describe a ruthenium-nickel bimetallic catalyst anchored inside the ordered channels of SBA-15 mesoporous silica, a system that converts linoleic acid into conjugated linoleic acid with a yield of 65 percent under optimized conditions while remaining active through four reuse cycles.</p>
<p>The appeal of the new work lies in its marriage of two ideas that catalyst designers have pursued separately for years: bimetallic synergy and structured mesoporous supports. Ruthenium has long been known as an active metal for the isomerization of linoleic acid, with earlier studies demonstrating that supported ruthenium catalysts can shift the double bonds of this C18 fatty acid from their natural methylene-interrupted positions into the conjugated arrangements that define CLA. Nickel, by contrast, is a cheaper metal with a well-documented tendency to drive hydrogenation, the very side reaction that consumes linoleic acid and turns it into saturated stearic acid instead of the desired conjugated product. On paper, pairing the two metals seems risky. In practice, the Jiangnan team found that the combination delivers something neither metal achieves alone.</p>
<p>The fabrication route is deliberately straightforward. The researchers first synthesized SBA-15, a well-known ordered mesoporous silica, using the triblock copolymer P123 as a structure-directing template and tetraethyl orthosilicate as the silicon source, following a hydrothermal method. SBA-15 is prized in catalysis for its uniform, cylindrical pores arranged in a two-dimensional hexagonal lattice, with pore diameters large enough, in this context, to accommodate bulky long-chain fatty acid molecules. The team then loaded the two metals by equal-volume co-impregnation, a technique in which a solution containing both metal precursors is introduced into the support in a controlled volume that matches the pore volume of the material, allowing the metals to deposit together throughout the porous network.</p>
<p>Characterization was central to establishing what actually formed inside the support. The researchers deployed a battery of standard techniques: X-ray diffraction to probe both the long-range order of the silica framework and the dispersion of the metal phases, scanning electron microscopy to image morphology, Brunauer-Emmett-Teller analysis to quantify surface area and porosity, and X-ray photoelectron spectroscopy to interrogate the electronic states of the metals. The results confirmed that the catalyst retains the intact ordered two-dimensional hexagonal cylindrical mesoporous structure of SBA-15 even after metal loading. Equally important, the metals were found to be highly dispersed rather than aggregated into large particles, a critical property because catalytic activity in these systems depends on exposing as many active surface atoms as possible to the reactant.</p>
<p>The electronic story that emerged from the characterization is where the work becomes genuinely interesting. X-ray photoelectron spectroscopy indicated that ruthenium and nickel interact electronically when co-deposited on the silica, forming what the authors describe as an electronic synergistic effect. In this division of labor, ruthenium serves as the dominant active site responsible for activating the carbon-carbon double bonds of linoleic acid, the essential first step in shifting those bonds into conjugated positions. Nickel, meanwhile, modulates the electron distribution at the active sites and, crucially, suppresses the unwanted hydrogenation side reactions that would otherwise degrade the fatty acid into saturated products. In other words, nickel does not merely dilute the ruthenium; it tunes the electronic environment so that the catalyst favors isomerization over full saturation.</p>
<p>This kind of metal-metal cooperation has precedent in the literature, which the authors situate carefully. A study dating back to 1988 reported isomerization of methyl linoleate over supported ruthenium-nickel catalysts, suggesting the pairing has historical roots. More recent work has explored related synergies, including ruthenium catalysts combined with basic sites on magnesium-aluminum supports for the same linoleic acid transformation, and ruthenium systems interacting with grafted niobium on SBA-15 for other reactions. The Jiangnan contribution is to bring this bimetallic concept together with the mesoporous architecture of SBA-15 in a single, recyclable system aimed specifically at green CLA synthesis, and to document the structural and electronic evidence for why it works.</p>
<p>The mesoporous support itself is not a passive bystander. The large pore size and straight, unobstructed channels of SBA-15 facilitate the diffusion of long-chain linoleic acid molecules, a nontrivial consideration when the reactant is an eighteen-carbon fatty acid that must physically reach the metal sites buried within the pore network. Smaller-pore supports can throttle this transport, limiting conversion and encouraging side reactions at the pore mouths. By preserving the ordered channel structure through synthesis and metal loading, the researchers ensured that the reactant can access the dispersed bimetallic sites efficiently, and that the products can diffuse back out without becoming trapped or over-reacted.</p>
<p>Performance testing under optimized conditions in an ethylene glycol solvent system delivered the headline result: a conjugated linoleic acid yield of 65 percent from linoleic acid isomerization. For a heterogeneous catalytic route to CLA, this figure represents a meaningful benchmark, particularly given the persistent challenge of balancing isomerization activity against hydrogenation selectivity. The choice of ethylene glycol as the reaction medium also aligns with the green chemistry framing of the work, since the overall system is presented as simple to prepare, cost-controllable, and environmentally friendly, in contrast to homogeneous routes that rely on expensive rhodium catalysts or generate separation burdens that complicate food-grade applications.</p>
<p>Recyclability may prove to be the most commercially consequential aspect of the report. Homogeneous catalysts, however active, are notoriously difficult to separate from fatty acid products, which is one reason heterogeneous approaches to CLA production have attracted sustained interest. The Ru-Ni/SBA-15 catalyst can be recovered by simple filtration, and the authors report that it remains stably active after being reused four times. That combination of separability and sustained activity addresses two of the biggest practical objections to catalytic CLA synthesis and brings the process closer to something a food or nutraceutical producer could realistically operate. The catalyst preparation itself, based on commodity silica, a polymer template, and relatively inexpensive nickel, also keeps raw material costs in check compared with precious-metal-only alternatives.</p>
<p>The broader significance of the study extends beyond CLA itself. Conjugated linoleic acid sits at the intersection of food science, nutrition, and catalysis, with reviews cataloguing effects on inflammation, oxidative stress, body composition, physical performance, and lipid metabolism in both animal and human contexts, and with biosynthetic routes also under active development. A robust, recyclable heterogeneous catalyst that performs the key isomerization step cleanly gives chemists and engineers a new tool for that supply chain. More generally, the work is a compact demonstration of a principle that continues to reshape catalysis research: that the deliberate pairing of metals, combined with a support architecture engineered for molecular transport, can produce cooperative behavior that no single-component system matches. As the Jiangnan team shows, sometimes the trick is not finding a better metal, but teaching two metals to work together inside a well-designed pore.</p>
<p><strong>Subject of Research:</strong> Ruthenium-nickel bimetallic catalysts on mesoporous SBA-15 for the green isomerization of linoleic acid to conjugated linoleic acid</p>
<p><strong>Article Title:</strong> Fabrication of Ru-Ni/SBA-15 Bimetallic Catalyst: Synergistic Effect and Application in Linoleic Acid Isomerization</p>
<p><strong>Article References:</strong> Fabrication of Ru-Ni/SBA-15 Bimetallic Catalyst: Synergistic Effect and Application in Linoleic Acid Isomerization. (n.d.). <a href="https://doi.org/10.1007/s10562-026-05539-6" rel="noopener noreferrer">https://doi.org/10.1007/s10562-026-05539-6</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1007/s10562-026-05539-6" rel="noopener noreferrer">10.1007/s10562-026-05539-6</a></p>
<p><strong>Keywords:</strong> conjugated linoleic acid, linoleic acid isomerization, bimetallic catalyst, ruthenium, nickel, SBA-15, mesoporous silica, heterogeneous catalysis, green catalysis, synergistic effect, catalyst recyclability, fatty acid chemistry</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">249145</post-id>	</item>
		<item>
		<title>Fatty Acid in Dairy Feed Shows Sweet Spot for Fighting Mastitis in Mouse Study</title>
		<link>https://scienmag.com/fatty-acid-in-dairy-feed-shows-sweet-spot-for-fighting-mastitis-in-mouse-study/</link>
		
		<dc:creator><![CDATA[Daisy Hatcher]]></dc:creator>
		<pubDate>Sat, 03 Oct 2026 17:33:11 +0000</pubDate>
				<category><![CDATA[Agriculture]]></category>
		<category><![CDATA[alternative approaches to antibiotic use in dairy industry]]></category>
		<category><![CDATA[anti-inflammatory properties of conjugated linoleic acid]]></category>
		<category><![CDATA[antioxidant enzymes]]></category>
		<category><![CDATA[CLA's role in mammary gland health]]></category>
		<category><![CDATA[conjugated linoleic acid]]></category>
		<category><![CDATA[conjugated linoleic acid health benefits]]></category>
		<category><![CDATA[cytokines]]></category>
		<category><![CDATA[dairy cow mastitis prevention]]></category>
		<category><![CDATA[dairy cows]]></category>
		<category><![CDATA[dairy product nutrition and inflammation]]></category>
		<category><![CDATA[dietary strategies for inflammation reduction]]></category>
		<category><![CDATA[dose-response]]></category>
		<category><![CDATA[economic impact of mastitis in dairy farming]]></category>
		<category><![CDATA[fatty acids in livestock feed]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[lipopolysaccharide]]></category>
		<category><![CDATA[livestock disease management with dietary supplements]]></category>
		<category><![CDATA[mammary gland]]></category>
		<category><![CDATA[mastitis]]></category>
		<category><![CDATA[natural sources of CLA in animal diets]]></category>
		<category><![CDATA[NF-κB]]></category>
		<category><![CDATA[non-linear dose response in nutrient studies]]></category>
		<category><![CDATA[Oxidative stress]]></category>
		<category><![CDATA[PPARγ]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=231122</guid>

					<description><![CDATA[A new mouse study finds that dietary conjugated linoleic acid protects mammary tissue from inflammation most effectively at a 1 percent dose, revealing a non-linear dose–response with implications for mastitis prevention in dairy cows.]]></description>
										<content:encoded><![CDATA[<p>A fatty acid already prized in nutrition circles may have found its most compelling role yet: shielding the mammary gland from the inflammatory damage that plagues dairy cows worldwide. In a new study published in Food Science &amp; Nutrition, researchers report that supplementing the diets of mice with conjugated linoleic acid, or CLA, significantly blunted inflammation in mammary tissue—but only at a specific dose. The finding, which reveals a striking non-linear dose–response relationship, could offer dairy farmers a dietary tool to combat mastitis, a disease responsible for enormous economic losses and a major driver of antibiotic use in livestock.</p>
<p>CLA is not a single molecule but a family of isomers of linoleic acid, distinguished by conjugated double bonds in their structure. It occurs naturally in meat fats and dairy products, with the cis-9, trans-11 isomer accounting for 80 to 90 percent of the CLA in milk. Over the past two decades, CLA has attracted attention for a remarkable range of physiological effects, including anti-cancer, anti-inflammatory, and anti-tumor activity, as well as the ability to reduce body fat and blood sugar. Previous work has shown that dietary CLA can raise levels of anti-inflammatory cytokines such as interleukin-10 in models of neuroinflammation, and that rumen-protected CLA alleviates mild systemic inflammation and oxidative stress in postpartum cows. Yet the literature also contains contradictions: some studies report enhanced antioxidant enzyme activity after CLA supplementation, while others find no significant antioxidant effect at all.</p>
<p>The research team, building on earlier cell-culture experiments with bovine mammary epithelial cells, set out to answer a deceptively simple question: what dose of dietary CLA best protects living animals from mammary inflammation? They turned to a mouse model in which pregnant females were fed diets containing 0.5 percent, 1 percent, or 2 percent CLA for seven weeks. The CLA preparation contained 80.4 percent CLA, split almost evenly between the cis-9, trans-11 and trans-10, cis-12 isomers, with small amounts of oleic, stearic, palmitic, and linoleic acids making up the remainder. Feed intake was statistically identical across all groups, ensuring that any differences in outcome could be attributed to the fatty acid itself rather than to changes in appetite or nutrition.</p>
<p>To provoke inflammation, the researchers injected lipopolysaccharide, or LPS, a component of bacterial cell walls, directly into the fourth mammary pair of each anesthetized mouse. LPS is a standard tool for triggering a controlled inflammatory response, and in the control animals it produced the expected damage: swollen mammary tissue, heavy infiltration of inflammatory cells, and elevated levels of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). These cytokines are the molecular messengers of inflammation, and their overproduction is a hallmark of mastitis in dairy cattle as well as of many inflammatory diseases in humans.</p>
<p>The results from blood and mammary tissue told a consistent story. In serum, all three CLA doses reduced malondialdehyde, or MDA, a key biomarker of lipid peroxidation and oxidative damage, while boosting superoxide dismutase (SOD) activity and total antioxidant capacity (T-AOC), two measures of the body&#8217;s antioxidant defenses. But the magnitude of change was not proportional to dose. The 1 percent CLA group achieved the lowest levels of MDA and the highest SOD activity and T-AOC in mammary tissue, with SOD and T-AOC increasing by roughly 5.71 percent and 6.29 percent respectively compared with controls. In serum, the same group showed the strongest antioxidant profile, with SOD and T-AOC elevated by 7.38 percent and 7.13 percent.</p>
<p>The anti-inflammatory effects were even more dramatic. In the serum of mice fed 1 percent CLA, IL-1β fell by 56.28 percent, TNF-α by 69.68 percent, and IL-6 by 40.93 percent relative to controls—by far the largest reductions among the three doses. In mammary tissue, the 1 percent group again led, with decreases of approximately 16 percent, 34 percent, and 13 percent for IL-1β, TNF-α, and IL-6. Gene expression analysis reinforced the pattern: the 1 percent group showed the greatest downregulation of TNF-α and IL-8 messenger RNA, while PPARγ, a nuclear receptor involved in metabolic and inflammatory regulation, was significantly increased only in the 2 percent group. Intriguingly, the highest PPARγ expression did not translate into the strongest anti-inflammatory outcome, hinting at possible saturation or negative feedback within the signaling pathway.</p>
<p>Histopathology provided the visual confirmation. Under the microscope, mammary acini in the control group were swollen and crowded with inflammatory cells, the classic signature of LPS-induced mastitis. Mice fed 0.5 percent CLA showed only modest improvement, and the 2 percent group, though better than control, still displayed noticeable infiltration in most glandular tissue. Only the 1 percent group preserved intact acinar architecture with minimal inflammatory infiltration—most glands appeared essentially normal. The authors suggest that at 0.5 percent, PPARγ activation was insufficient to block the nuclear translocation of NF-κB, the master switch of the inflammatory cascade, whereas 1 percent achieved moderate PPARγ activation that maximally suppressed downstream cytokine release without triggering feedback inhibition.</p>
<p>The mechanism most likely centers on the interplay between PPARγ and NF-κB. PPARγ is known to interact with NF-κB and prevent its entry into the nucleus, thereby suppressing transcription of TNF-α, IL-1, and IL-6. Prior studies have shown that CLA downregulates inflammatory cytokine mRNA in macrophages via the PPARγ pathway, and that PPARγ activation is the core mechanism by which CLA alleviates colitis. The researchers are careful to note, however, that their study measured only PPARγ mRNA and did not verify protein activation or the physical interaction between PPARγ and NF-κB, so the proposed mechanism remains a plausible hypothesis rather than a confirmed causal chain. The unexpected finding that GPx activity decreased in the CLA groups is also interpreted with nuance: rather than indicating impaired antioxidant capacity, the authors argue it may simply reflect a reduced oxidative burden, since less oxidative stress means less need for the enzyme.</p>
<p>Translating the mouse data to the dairy barn requires caution. Using the Meeh-Rubner formula for body surface area, the researchers estimated that the daily CLA intake of a mouse on the 1 percent diet falls within a range broadly similar to the 20 to 100 grams per day of rumen-protected CLA typically used in cattle trials. But the two species differ fundamentally in how they handle unsaturated fatty acids. As a monogastric animal, the mouse absorbs CLA directly in the small intestine. In ruminants, rumen microbes biohydrogenate most unprotected unsaturated fatty acids into stearic acid, rendering plain CLA nearly useless. Any practical application in dairy cows would therefore require rumen-protected formulations, and doses cannot simply be scaled by body weight.</p>
<p>Even with those caveats, the study delivers a clear and actionable message: more is not always better. The 1 percent dietary inclusion of CLA outperformed both lower and higher doses across every measure of antioxidant capacity, cytokine suppression, gene expression, and tissue integrity. For a dairy industry under pressure to reduce antibiotic use while maintaining milk quality and yield, a precisely dosed fatty acid supplement that protects the mammary gland from within could be a genuinely valuable addition to the herd&#8217;s diet. The next step—validating the optimal dose in actual lactating cows with rumen-protected CLA—will determine whether this mouse study becomes the foundation of a new era in mastitis prevention.</p>
<p><strong>Subject of Research:</strong> Dose-dependent effects of dietary conjugated linoleic acid on antioxidant and anti-inflammatory function of the mammary gland in mice</p>
<p><strong>Article Title:</strong> Effects of Supplementing the Diets of Mice With Different Concentrations of Conjugated Linoleic Acid on the Anti‐Inflammatory Function of the Mammary Gland</p>
<p><strong>Article References:</strong> Ren, Z., Liang, W., Zhang, H., Liu, M., &amp; Wang, Y. (2026). Effects of Supplementing the Diets of Mice With Different Concentrations of Conjugated Linoleic Acid on the Anti‐Inflammatory Function of the Mammary Gland. <em>Food Science &amp;amp; Nutrition, 14</em>(10), Article e72367. <a href="https://doi.org/10.1002/fsn3.72367" rel="noopener noreferrer">https://doi.org/10.1002/fsn3.72367</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1002/fsn3.72367" rel="noopener noreferrer">10.1002/fsn3.72367</a></p>
<p><strong>Keywords:</strong> conjugated linoleic acid, mastitis, mammary gland, oxidative stress, inflammation, dairy cows, PPARγ, NF-κB, cytokines, antioxidant enzymes, lipopolysaccharide, dose-response</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">231122</post-id>	</item>
	</channel>
</rss>
